Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3297
-0.0053 (-1.58%)
At close: Aug 29, 2025, 4:00 PM
0.3246
-0.0051 (-1.55%)
After-hours: Aug 29, 2025, 7:56 PM EDT
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $12.70 million as of August 29, 2025. Its market cap has decreased by -67.10% in one year.
Market Cap
12.70M
Enterprise Value
1.04M
1-Year Change
-67.10%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $12.70M, a decrease of -80.46%. That is a compound annual growth rate of -18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 12.70M | -46.86% |
| Dec 31, 2024 | 23.90M | -41.28% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
| Jul 12, 2017 | 65.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |